Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
10.1038/s41375-020-0819-8
Saved in:
Main Authors: | Goldschmidt, Hartmut, Dimopoulos, Meletios A, Rajkumar, S Vincent, Weisel, Katja C, Moreau, Philippe, Chng, Wee-Joo, Mikala, Gabor, Cavo, Michele, Ramasamy, Karthik, Suryanarayan, Kaveri, Teng, Zhaoyang, Labotka, Richard, Victoria Mateos, Maria |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Article |
Language: | English |
Published: |
SPRINGERNATURE
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
by: Dimopoulos, Meletios A, et al.
Published: (2022) -
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
by: Chng, WJ, et al.
Published: (2023) -
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
by: Moreau, P, et al.
Published: (2022) -
The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
by: Tan, D., et al.
Published: (2016) -
Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016)